Toward trustworthy healthcare AI: designing academic research for translation readiness.

IF 6.7 1区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Molecular Systems Biology Pub Date : 2026-08-01 Epub Date: 2026-05-27 DOI:10.1038/s44320-026-00219-4
Achim Hekler, Florian Buettner
{"title":"Toward trustworthy healthcare AI: designing academic research for translation readiness.","authors":"Achim Hekler, Florian Buettner","doi":"10.1038/s44320-026-00219-4","DOIUrl":null,"url":null,"abstract":"<p><p>In controlled proof-of-concept studies, healthcare artificial intelligence (AI) systems now routinely match or exceed specialist-level performance. Despite these impressive technical achievements, most systems remain confined to research settings, highlighting an opportunity to better prepare academic AI research for subsequent clinical translation. Successful translation requires attention to technical, regulatory, organizational, and infrastructural factors, ideally from the earliest stages of research. This Perspective focuses on trustworthiness as a key factor that academic researchers can address proactively. First, we outline how trustworthiness requirements differ across three stakeholder groups-patients, clinicians, and regulatory bodies-and how academic research can better align with these expectations. We then discuss key dimensions of trustworthy AI-explainability, uncertainty quantification, and evaluation-and how researchers can address them during study design. We also consider foundation models, which require adapted validation approaches. Based on this analysis, we propose a stakeholder-centered framework that emphasizes proactive integration of trust requirements during early development phases rather than post hoc considerations.</p>","PeriodicalId":18906,"journal":{"name":"Molecular Systems Biology","volume":" ","pages":"1201-1213"},"PeriodicalIF":6.7000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13434723/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Systems Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s44320-026-00219-4","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In controlled proof-of-concept studies, healthcare artificial intelligence (AI) systems now routinely match or exceed specialist-level performance. Despite these impressive technical achievements, most systems remain confined to research settings, highlighting an opportunity to better prepare academic AI research for subsequent clinical translation. Successful translation requires attention to technical, regulatory, organizational, and infrastructural factors, ideally from the earliest stages of research. This Perspective focuses on trustworthiness as a key factor that academic researchers can address proactively. First, we outline how trustworthiness requirements differ across three stakeholder groups-patients, clinicians, and regulatory bodies-and how academic research can better align with these expectations. We then discuss key dimensions of trustworthy AI-explainability, uncertainty quantification, and evaluation-and how researchers can address them during study design. We also consider foundation models, which require adapted validation approaches. Based on this analysis, we propose a stakeholder-centered framework that emphasizes proactive integration of trust requirements during early development phases rather than post hoc considerations.

迈向值得信赖的医疗人工智能:为翻译准备设计学术研究。
在受控的概念验证研究中,医疗保健人工智能(AI)系统现在通常达到或超过专家水平的性能。尽管取得了这些令人印象深刻的技术成就,但大多数系统仍然局限于研究环境,这凸显了为后续临床转化更好地准备人工智能学术研究的机会。成功的翻译需要关注技术、法规、组织和基础设施因素,最好从研究的最初阶段开始。这一视角将诚信作为学术研究人员可以主动解决的关键因素。首先,我们概述了三个利益相关者群体(患者、临床医生和监管机构)对可信度的要求有何不同,以及学术研究如何更好地符合这些期望。然后,我们讨论了可信赖人工智能的关键维度——可解释性、不确定性量化和评估——以及研究人员如何在研究设计期间解决这些问题。我们还考虑基础模型,它需要适应的验证方法。基于这一分析,我们提出了一个以利益相关者为中心的框架,强调在早期开发阶段主动整合信任需求,而不是事后考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Systems Biology
Molecular Systems Biology 生物-生化与分子生物学
CiteScore
18.50
自引率
1.00%
发文量
62
审稿时长
6-12 weeks
期刊介绍: Systems biology is a field that aims to understand complex biological systems by studying their components and how they interact. It is an integrative discipline that seeks to explain the properties and behavior of these systems. Molecular Systems Biology is a scholarly journal that publishes top-notch research in the areas of systems biology, synthetic biology, and systems medicine. It is an open access journal, meaning that its content is freely available to readers, and it is peer-reviewed to ensure the quality of the published work.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书